B. van-Ommen

HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial

D. Gómez-Coronado, J. Ordovás, J. Martínez‐Botas, 2017, Scientific Reports.

HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial

D. Gómez-Coronado, J. Ordovás, J. Martínez‐Botas, 2017, Scientific Reports.

Hepatic insulin resistance both in prediabetic and diabetic patients determines postprandial lipoprotein metabolism: from the CORDIOPREV study

M. Malagón, P. Pérez-Martínez, A. Camargo, 2016, Cardiovascular Diabetology.